Chris Fukuda, M.D.
PersonMentions
2
Relationships
1
Events
1
Documents
1
Relationship Network
Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons.
Drag nodes to reposition. Node size indicates connection count.
Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak).
Use legend and help buttons in the graph for more guidance.
Event Timeline
Interactive Timeline: Hover over events to see details. Events are arranged chronologically and alternate between top and bottom for better visibility.
1 total relationships
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Lawrence Agee
|
Business associate |
5
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| 2004-10-01 | N/A | Court decision rendered in Agee v. Grunert et al. | Vermont | View |
HOUSE_OVERSIGHT_017903.jpg
This document is a page from the Federal Supplement (Vol. 349, 2d Series) containing the header of a decision in the case *Lawrence Agee v. Richard Grunert, et al.* (D. Vermont, 2004). The case involves a physician suing his former partners for defamation and other torts after they reported his mental unfitness to practice; the court largely ruled in favor of the defendants, finding their statements privileged and required by ethics codes. The top of the page also contains the conclusion of a separate, unrelated case involving the 'SAAR Network' and 'Adel Batterjee' (likely the *Burnett* 9/11 litigation), and the footer indicates the document is part of a House Oversight Committee production.
Legal document (federal supplement court opinion)
2025-11-19
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity